A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome

Clinical trial NCT01906307 · TERMINATED

Trial details

NCT number: NCT01906307
Sponsor: La Jolla Pharmaceutical Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatorenal Syndrome Type I and Type II

Start date: 2014-03-01
Primary completion: 2015-11-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.